Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary
.
The global Pertussis Vaccine market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Pertussis Vaccine are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Pertussis Vaccine market segmented into
Children
Acellular vaccines
Others

Based on the end-use, the global Pertussis Vaccine market classified into
Children
Adults

Based on geography, the global Pertussis Vaccine market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
Astellas Pharma
Minhai Biotechnology
Wuhan Institute of
Biological Products
Changchun Changsheng
Life Sciences
Beijing Tiantan
Biological Products
Chengdu Institute of
Biological Products

Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL PERTUSSIS VACCINE INDUSTRY
2.1 Summary about Pertussis Vaccine Industry
2.2 Pertussis Vaccine Market Trends
2.2.1 Pertussis Vaccine Production & Consumption Trends
2.2.2 Pertussis Vaccine Demand Structure Trends
2.3 Pertussis Vaccine Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Whole-cell vaccines
4.2.2 Acellular vaccines
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Children
4.3.2 Adults
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Whole-cell vaccines
5.2.2 Acellular vaccines
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Children
5.3.2 Adults
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Whole-cell vaccines
6.2.2 Acellular vaccines
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Children
6.3.2 Adults
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Whole-cell vaccines
7.2.2 Acellular vaccines
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Children
7.3.2 Adults
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Whole-cell vaccines
8.2.2 Acellular vaccines
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Children
8.3.2 Adults
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Whole-cell vaccines
9.2.2 Acellular vaccines
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Children
9.3.2 Adults
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Sanofi Pasteur
10.1.2 GSK
10.1.3 Mitsubishi Tanabe Pharma
10.1.4 Astellas Pharma
10.1.5 Minhai Biotechnology
10.1.6 Wuhan Institute of
10.1.7 Biological Products
10.1.8 Changchun Changsheng
10.1.9 Life Sciences
10.1.10 Beijing Tiantan
10.1.11 Biological Products
10.1.12 Chengdu Institute of
10.1.13 Biological Products
10.2 Pertussis Vaccine Sales Date of Major Players (2017-2020e)
10.2.1 Sanofi Pasteur
10.2.2 GSK
10.2.3 Mitsubishi Tanabe Pharma
10.2.4 Astellas Pharma
10.2.5 Minhai Biotechnology
10.2.6 Wuhan Institute of
10.2.7 Biological Products
10.2.8 Changchun Changsheng
10.2.9 Life Sciences
10.2.10 Beijing Tiantan
10.2.11 Biological Products
10.2.12 Chengdu Institute of
10.2.13 Biological Products
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT


List of Table
1.Table Pertussis Vaccine Product Type Overview
2.Table Pertussis Vaccine Product Type Market Share List
3.Table Pertussis Vaccine Product Type of Major Players
4.Table Brief Introduction of Sanofi Pasteur
5.Table Brief Introduction of GSK
6.Table Brief Introduction of Mitsubishi Tanabe Pharma
7.Table Brief Introduction of Astellas Pharma
8.Table Brief Introduction of Minhai Biotechnology
9.Table Brief Introduction of Wuhan Institute of
10.Table Brief Introduction of Biological Products
11.Table Brief Introduction of Changchun Changsheng
12.Table Brief Introduction of Life Sciences
13.Table Brief Introduction of Beijing Tiantan
14.Table Brief Introduction of Biological Products
15.Table Brief Introduction of Chengdu Institute of
16.Table Brief Introduction of Biological Products
17.Table Products & Services of Sanofi Pasteur
18.Table Products & Services of GSK
19.Table Products & Services of Mitsubishi Tanabe Pharma
20.Table Products & Services of Astellas Pharma
21.Table Products & Services of Minhai Biotechnology
22.Table Products & Services of Wuhan Institute of
23.Table Products & Services of Biological Products
24.Table Products & Services of Changchun Changsheng
25.Table Products & Services of Life Sciences
26.Table Products & Services of Beijing Tiantan
27.Table Products & Services of Biological Products
28.Table Products & Services of Chengdu Institute of
29.Table Products & Services of Biological Products
30.Table Market Distribution of Major Players
31.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
32.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
33.Table Global Pertussis Vaccine Market Forecast (Million USD) by Region 2021f-2026f
34.Table Global Pertussis Vaccine Market Forecast (Million USD) Share by Region 2021f-2026f
35.Table Global Pertussis Vaccine Market Forecast (Million USD) by Demand 2021f-2026f
36.Table Global Pertussis Vaccine Market Forecast (Million USD) Share by Demand 2021f-2026f

List of Figure
1.Figure Global Pertussis Vaccine Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Pertussis Vaccine Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Pertussis Vaccine Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Pertussis Vaccine Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Pertussis Vaccine Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Pertussis Vaccine Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Pertussis Vaccine Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Whole-cell vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Acellular vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Whole-cell vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Acellular vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Whole-cell vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Acellular vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Whole-cell vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Acellular vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Whole-cell vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Acellular vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Whole-cell vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Acellular vaccines Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Children Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Adults Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Pertussis Vaccine Sales Revenue (Million USD) of Sanofi Pasteur 2017-2020e
66.Figure Pertussis Vaccine Sales Revenue (Million USD) of GSK 2017-2020e
67.Figure Pertussis Vaccine Sales Revenue (Million USD) of Mitsubishi Tanabe Pharma 2017-2020e
68.Figure Pertussis Vaccine Sales Revenue (Million USD) of Astellas Pharma 2017-2020e
69.Figure Pertussis Vaccine Sales Revenue (Million USD) of Minhai Biotechnology 2017-2020e
70.Figure Pertussis Vaccine Sales Revenue (Million USD) of Wuhan Institute of 2017-2020e
71.Figure Pertussis Vaccine Sales Revenue (Million USD) of Biological Products 2017-2020e
72.Figure Pertussis Vaccine Sales Revenue (Million USD) of Changchun Changsheng 2017-2020e
73.Figure Pertussis Vaccine Sales Revenue (Million USD) of Life Sciences 2017-2020e
74.Figure Pertussis Vaccine Sales Revenue (Million USD) of Beijing Tiantan 2017-2020e
75.Figure Pertussis Vaccine Sales Revenue (Million USD) of Biological Products 2017-2020e
76.Figure Pertussis Vaccine Sales Revenue (Million USD) of Chengdu Institute of 2017-2020e
77.Figure Pertussis Vaccine Sales Revenue (Million USD) of Biological Products 2017-2020e
78.

Global Cold Chain Equipment Market (2024 Edition): Analysis By Equipment Type (Refrigerators, Deep Freezers & Reefer Containers, Cold Boxes & Vaccine Carriers, Cold Rooms/ Chillers, Other Equipment Types), By Purpose, By End-use, By Region, By Country: Market Insights and Forecast (2020-2030)...

Executive Summary Azoth Analytics has released a research report titled "Global Cold Chain Equipment Market (2024 Edition)" which provides a complete analysis of the Global Cold Chain Equipment market in terms of market segmentation By Equipment Type (Refrigerators, Deep Freezers & Reef...

Global Vaccine Supply Chain Solutions Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Vaccine Supply Chain Solutions Market: The report discusses everything a marketer requires before investing in the global Vaccine Supply Chain Solutions Market during the forecast period 2023-...

Global Digital Vaccine Tracking System Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2030...

Overview of the Global Digital Vaccine Tracking System Market: The report discusses everything a marketer requires before investing in the global Digital Vaccine Tracking System Market during the forecast period 202...

Asia Pacific Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Asia Pacific preventive vaccines market will grow by 7.9% annually with a total addressable market cap of $217.46 billion over 2023-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for p...

Europe Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

Europe preventive vaccines market was valued at $18.02 billion in 2022 and will grow by 5.1% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines s...

North America Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Country: Trend Forecast and Growth Opportunity...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for pre...

Global Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, Administration, Patient, and Region: Trend Forecast and Growth Opportunity...

Global preventive vaccines market will reach $120.07 billion by 2032, growing by 6.4% annually over 2022-2032, driven by the rising prevalence of several infectious diseases, rising R&D investment and technological advancement in vaccination technologies, rising need for preventive vaccines such as ...

2023-2028 Global and Regional Whole Cell Cholera Vaccine Industry Status and Prospects Professional Market Research Report Standard Version...

The global Whole Cell Cholera Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players i...

2023-2028 Global and Regional Viral Vaccine Media Industry Status and Prospects Professional Market Research Report Standard Version...

The global Viral Vaccine Media market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this ...

2023-2028 Global and Regional Vero Cell Rabies Vaccine Industry Status and Prospects Professional Market Research Report Standard Version...

The global Vero Cell Rabies Vaccine market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in ...